• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Treatment of fistulizing inflammatory bowel disease.

作者信息

Schwartz David A, Maltz Brad E

机构信息

Division of Gastroenterology, Vanderbilt University Medical Center, Suite 514, 1211 21st Avenue, Nashville, TN 37232, USA.

出版信息

Med Clin North Am. 2010 Jan;94(1):19-34. doi: 10.1016/j.mcna.2009.08.020.

DOI:10.1016/j.mcna.2009.08.020
PMID:19944796
Abstract

Fistulas manifest frequently in Crohn disease and can result in significant morbidity and often lead to the need for surgical intervention. Historically, it has been more difficult to obtain complete fistula closure in patients with perianal Crohn disease. Anti-tumor necrosis factor-alpha agents and the use of more accurate imaging modalities such as magnetic resonance imaging and rectal endoscopic ultrasound have enhanced the ability to manage fistulizing Crohn disease. A combined medical and surgical approach usually presents the best option for most patients.

摘要

相似文献

1
Treatment of fistulizing inflammatory bowel disease.
Med Clin North Am. 2010 Jan;94(1):19-34. doi: 10.1016/j.mcna.2009.08.020.
2
Treatment of fistulizing inflammatory bowel disease.瘘管性炎症性肠病的治疗。
Gastroenterol Clin North Am. 2009 Dec;38(4):595-610. doi: 10.1016/j.gtc.2009.07.009.
3
Perianal fistulizing Crohn's disease: a call to action.肛周瘘管性克罗恩病:行动呼吁。
Clin Gastroenterol Hepatol. 2008 Jan;6(1):7-10. doi: 10.1016/j.cgh.2007.10.010. Epub 2007 Dec 11.
4
Medical treatment of perianal Crohn disease.肛周克罗恩病的医学治疗
Saudi J Gastroenterol. 2002 Sep;8(3):74-80.
5
Novel diagnostic and prognostic modalities in inflammatory bowel disease.炎症性肠病的新型诊断和预后方法。
Med Clin North Am. 2010 Jan;94(1):155-78. doi: 10.1016/j.mcna.2009.10.003.
6
[Surgery, inflammatory bowel disease and biological treatment].[外科手术、炎症性肠病与生物治疗]
Tidsskr Nor Laegeforen. 2009 Nov 19;129(22):2389-90. doi: 10.4045/tidsskr.09.1231.
7
Biologic therapy in Crohn's disease.克罗恩病的生物治疗
Mo Med. 2009 Sep-Oct;106(5):356-60.
8
Safety profile of IBD therapeutics: infectious risks.炎症性肠病治疗药物的安全性概况:感染风险
Med Clin North Am. 2010 Jan;94(1):115-33. doi: 10.1016/j.mcna.2009.08.016.
9
Long-term safety of Infliximab for the treatment of inflammatory bowel disease: does blocking TNFalpha reduce colitis-associated colorectal carcinogenesis?英夫利昔单抗治疗炎症性肠病的长期安全性:阻断肿瘤坏死因子α是否能降低结肠炎相关的结直肠癌发生风险?
Gut. 2009 Dec;58(12):1703. doi: 10.1136/gut.2008.176461.
10
Outpatient experimental treatment for uncomplicated perianal fistulas.单纯性肛周瘘的门诊实验性治疗
Int Surg. 2008 Jul-Aug;93(4):202-5.

引用本文的文献

1
Fistula tract curettage and the use of biological dermal plugs improve high transsphincteric fistula healing in an animal model.瘘管刮除术及生物真皮塞的应用可改善动物模型中高位经括约肌肛瘘的愈合情况。
Int J Colorectal Dis. 2016 Feb;31(2):291-9. doi: 10.1007/s00384-015-2374-8. Epub 2015 Aug 27.
2
AST-120 (spherical carbon adsorbent) in the treatment of perianal fistulae in mild-to-moderate Crohn's disease: FHAST-1, a phase 3, multicenter, placebo-controlled study.AST-120(球形碳吸附剂)治疗轻至中度克罗恩病肛周瘘管:FHAST-1,一项3期、多中心、安慰剂对照研究
Inflamm Bowel Dis. 2014 May;20(5):872-81. doi: 10.1097/MIB.0000000000000031.
3
Stem cells as potential therapeutic targets for inflammatory bowel disease.
干细胞作为炎症性肠病的潜在治疗靶点。
Front Biosci (Schol Ed). 2010 Jun 1;2(3):993-1008. doi: 10.2741/s115.